Clinical Trial Update: MEDI5752 in Patients With Mature Tertiary Lymphoid Structures Solid Tumors. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for MEDI5752 in mature tertiary lymphoid structure solid tumors; the study in advanced solid tumors is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• MEDI5752

Snippet

Sponsor: Institut Bergonié | Conditions: Advanced Solid Tumor | Phase 2 | Status: NOT_YET_RECRUITING